| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyBiologicalProcess | chaperone cofactor-dependent protein refolding | 2.19e-05 | 35 | 202 | 5 | GO:0051085 | |
| GeneOntologyBiologicalProcess | protein folding | TTC1 DNAJC7 TTC4 HSP90AA5P DNAJB14 PPIL2 DNAJC1 HSPA2 HSPA5 HSP90AA1 ERO1A | 3.26e-05 | 246 | 202 | 11 | GO:0006457 |
| GeneOntologyBiologicalProcess | 'de novo' post-translational protein folding | 4.82e-05 | 41 | 202 | 5 | GO:0051084 | |
| GeneOntologyBiologicalProcess | mechanoreceptor differentiation | 7.42e-05 | 104 | 202 | 7 | GO:0042490 | |
| GeneOntologyBiologicalProcess | inner ear receptor cell development | 8.08e-05 | 73 | 202 | 6 | GO:0060119 | |
| GeneOntologyBiologicalProcess | 'de novo' protein folding | 8.48e-05 | 46 | 202 | 5 | GO:0006458 | |
| MousePheno | abnormal sublingual gland morphology | 3.21e-06 | 10 | 159 | 4 | MP:0004035 | |
| MousePheno | ventricular septal defect | ZMYND11 PDGFRA TRIP11 SYT1 BAIAP2 DNAH5 ECE1 CCDC39 IFT88 XIRP2 SH3PXD2A SMARCD3 RERE | 8.89e-06 | 261 | 159 | 13 | MP:0010402 |
| MousePheno | abnormal interventricular septum morphology | ZMYND11 PDGFRA TRIP11 SYT1 BAIAP2 ADGRL2 DNAH5 ECE1 CCDC39 IFT88 XIRP2 SH3PXD2A SMARCD3 RERE | 3.61e-05 | 342 | 159 | 14 | MP:0000281 |
| MousePheno | abnormal body wall morphology | PDGFRA TRIP11 DNAJB14 MAP3K4 STRADA SYT1 RBM45 SH3PXD2A ROCK1 | 5.66e-05 | 151 | 159 | 9 | MP:0003385 |
| MousePheno | abnormal thyroid gland morphology | 5.88e-05 | 87 | 159 | 7 | MP:0000681 | |
| MousePheno | abnormal heart atrium morphology | ZMYND11 PDGFRA FGF10 ADGRL2 DNAH5 RBM20 CCDC39 IFT88 XIRP2 SH3PXD2A SMARCD3 | 6.95e-05 | 232 | 159 | 11 | MP:0003105 |
| MousePheno | enlarged brain ventricles | STRADA PPM1L DNAH5 PDCD6IP NRDC CCDC39 SH3PXD2A PAFAH1B1 KDM4B | 7.29e-05 | 156 | 159 | 9 | MP:0011380 |
| MousePheno | postnatal lethality | ASXL1 PDGFRA SPTB HMGCS2 NEB TTC8 STRADA PPM1L SCN9A SYT1 USP1 DNAH5 ANK3 NRDC RBL1 NTRK2 APOB TF CCDC39 IFT88 XIRP2 LMO7 PAFAH1B1 ROCK1 ELF3 RERE FUT8 | 8.72e-05 | 1084 | 159 | 27 | MP:0002082 |
| MousePheno | abnormal brain ventricle size | STRADA PPM1L DNAH5 PDCD6IP NRDC CCDC39 SH3PXD2A PAFAH1B1 KDM4B | 1.07e-04 | 164 | 159 | 9 | MP:0013229 |
| MousePheno | abnormal heart septum morphology | ZMYND11 PDGFRA TRIP11 SYT1 BAIAP2 ADGRL2 DNAH5 ECE1 CCDC39 IFT88 XIRP2 SH3PXD2A SMARCD3 RERE | 1.39e-04 | 388 | 159 | 14 | MP:0006113 |
| MousePheno | abnormal vein morphology | 1.83e-04 | 176 | 159 | 9 | MP:0002725 | |
| Domain | TPR_1 | 4.95e-07 | 90 | 199 | 9 | IPR001440 | |
| Domain | TPR_1 | 4.95e-07 | 90 | 199 | 9 | PF00515 | |
| Domain | TPR | 1.23e-06 | 129 | 199 | 10 | SM00028 | |
| Domain | TPR-like_helical_dom | SART3 TTC1 DNAJC7 TTC4 GTF3C3 TTC8 SMYD4 UTY NAA15 TEX11 PPP5C IFT88 PDCD11 | 1.35e-06 | 233 | 199 | 13 | IPR011990 |
| Domain | TPR_repeat | 1.63e-06 | 133 | 199 | 10 | IPR019734 | |
| Domain | - | TTC1 DNAJC7 TTC4 GTF3C3 TTC8 SMYD4 UTY NAA15 TEX11 PPP5C IFT88 PDCD11 | 2.34e-06 | 207 | 199 | 12 | 1.25.40.10 |
| Domain | TPR-contain_dom | 4.83e-06 | 150 | 199 | 10 | IPR013026 | |
| Domain | OLF | 8.29e-06 | 13 | 199 | 4 | PF02191 | |
| Domain | OLF | 8.29e-06 | 13 | 199 | 4 | PS51132 | |
| Domain | Olfac-like_dom | 8.29e-06 | 13 | 199 | 4 | IPR003112 | |
| Domain | OLF | 8.29e-06 | 13 | 199 | 4 | SM00284 | |
| Domain | TPR_8 | 2.05e-05 | 53 | 199 | 6 | PF13181 | |
| Domain | TPR_REGION | 7.07e-05 | 165 | 199 | 9 | PS50293 | |
| Domain | TPR | 7.07e-05 | 165 | 199 | 9 | PS50005 | |
| Domain | Secretoglobin_1C1/2 | 1.13e-04 | 2 | 199 | 2 | IPR028659 | |
| Domain | Elongated_TPR_rpt_dom | 1.85e-04 | 11 | 199 | 3 | IPR023114 | |
| Domain | Recoverin | 3.15e-04 | 13 | 199 | 3 | IPR028846 | |
| Domain | Calsyntenin | 3.36e-04 | 3 | 199 | 2 | IPR026914 | |
| Domain | Latrophilin | 3.36e-04 | 3 | 199 | 2 | PF02354 | |
| Domain | GPCR_2_latrophilin_rcpt_C | 3.36e-04 | 3 | 199 | 2 | IPR003334 | |
| Domain | EF-hand_8 | 4.51e-04 | 34 | 199 | 4 | PF13833 | |
| Domain | - | 6.68e-04 | 4 | 199 | 2 | 3.90.1460.10 | |
| Domain | Nebulin | 6.68e-04 | 4 | 199 | 2 | PF00880 | |
| Domain | NEBULIN | 6.68e-04 | 4 | 199 | 2 | PS51216 | |
| Domain | NEBU | 6.68e-04 | 4 | 199 | 2 | SM00227 | |
| Domain | Nebulin | 6.68e-04 | 4 | 199 | 2 | IPR013998 | |
| Domain | GTF2I | 6.68e-04 | 4 | 199 | 2 | PS51139 | |
| Domain | GTF2I | 6.68e-04 | 4 | 199 | 2 | PF02946 | |
| Domain | Nebulin_repeat | 6.68e-04 | 4 | 199 | 2 | IPR000900 | |
| Domain | GTF2I | 6.68e-04 | 4 | 199 | 2 | IPR004212 | |
| Domain | Gal_Lectin | 1.11e-03 | 5 | 199 | 2 | PF02140 | |
| Domain | GPCR_2_latrophilin | 1.11e-03 | 5 | 199 | 2 | IPR003924 | |
| Domain | Lectin_gal-bd_dom | 1.11e-03 | 5 | 199 | 2 | IPR000922 | |
| Domain | SUEL_LECTIN | 1.11e-03 | 5 | 199 | 2 | PS50228 | |
| Pathway | REACTOME_PHASE_1_INACTIVATION_OF_FAST_NA_CHANNELS | 4.01e-05 | 7 | 150 | 3 | M27457 | |
| Pathway | REACTOME_PHASE_1_INACTIVATION_OF_FAST_NA_CHANNELS | 4.01e-05 | 7 | 150 | 3 | MM15199 | |
| Pubmed | CLSTN3 TTLL5 SPTB DNAJC7 TRIP11 HMG20A MORF4L1 BAIAP2 HSPA2 HSPA5 BTRC HSP90AA1 YPEL3 CNTN4 ANK3 HECTD4 CACHD1 TF ZNF181 PPP5C IFT88 LMO7 ATRNL1 PNMA2 ERC2 FUT8 NEUROD6 RSBN1L XPOT | 5.67e-10 | 1285 | 204 | 29 | 35914814 | |
| Pubmed | SART3 CENPF NEB DNAJC7 DNAJB14 ERLEC1 MDN1 CTAGE1 SCN9A GTF2IRD2 DLG3 BSN USP1 HSPA2 HSPA5 HSP90AA1 APOB TMEM43 ECE1 ADAMTS12 GTF2IRD2B IFT88 LMO7 SH3PXD2A ARHGAP12 ERC2 ATP12A TOP2B DOP1A | 7.55e-09 | 1442 | 204 | 29 | 35575683 | |
| Pubmed | DNAJC7 WWC2 PPM1L BAIAP2 PIBF1 ADGRL2 USP1 HSPA2 HSPA5 BTRC HSP90AA1 ARMT1 ANK3 POLR2B RALGAPB RNF213 CACHD1 RBM20 PPP5C PNMA2 ROCK1 MPHOSPH9 XPOT | 6.69e-08 | 1049 | 204 | 23 | 27880917 | |
| Pubmed | 7.19e-08 | 61 | 204 | 7 | 19875381 | ||
| Pubmed | Scanning the human proteome for calmodulin-binding proteins. | 7.45e-08 | 92 | 204 | 8 | 15840729 | |
| Pubmed | SPTB YTHDC1 HSP90AA5P ZNF585B TTC8 PARP4 MYO3B SYT1 ADGRL2 ARAP2 NIBAN1 OLFM4 ECE1 CD53 KCNIP4 GREB1 ATP12A FUT8 LRIF1 RSBN1L | 8.36e-08 | 814 | 204 | 20 | 23251661 | |
| Pubmed | SART3 DNAJC7 ERLEC1 LCLAT1 MDN1 SQSTM1 DNAJC1 FAR1 ADGRL2 HSPA2 BTRC HSP90AA1 CUL2 PDCD6IP EEF1E1 ERO1A DDX60 POLR2B RNF213 TMEM43 CTSA ANKRD13A LMO7 PDCD11 TOP2B LRRFIP2 XPOT | 1.08e-07 | 1440 | 204 | 27 | 30833792 | |
| Pubmed | LMBR1L regulates lymphopoiesis through Wnt/β-catenin signaling. | CLSTN3 DNAJC7 DNAJB14 ERLEC1 GTF3C3 LCLAT1 SQSTM1 MTX3 PPIL2 FAR1 ADGRL2 HSPA2 NAA15 PDCD6IP POLR2B CACHD1 CLSTN1 ANKRD13A FUT8 ZNF281 XPOT | 1.97e-07 | 942 | 204 | 21 | 31073040 |
| Pubmed | A central chaperone-like role for 14-3-3 proteins in human cells. | PDGFRA NET1 TRIP11 FSIP2 WWC2 BMX MDN1 SQSTM1 BAIAP2 PIBF1 ARAP2 KRT78 NAA15 PDCD6IP RALGAPB LARP1B LMO7 SH3PXD2A MPHOSPH9 DOP1A | 2.05e-07 | 861 | 204 | 20 | 36931259 |
| Pubmed | A high-throughput approach for measuring temporal changes in the interactome. | SART3 MYL6 TTC1 DNAJC7 TTC4 SQSTM1 HSPA5 HSP90AA1 CUL2 NIBAN1 NAA15 PDCD6IP NRDC EEF1E1 ERO1A CAPN1 POLR2B CTSA PPP5C WDHD1 ASMTL PAFAH1B1 PNMA2 NT5C2 ROCK1 XPOT | 4.75e-07 | 1455 | 204 | 26 | 22863883 |
| Pubmed | Differential distribution of KChIPs mRNAs in adult mouse brain. | 7.92e-07 | 4 | 204 | 3 | 15363885 | |
| Pubmed | 7.92e-07 | 4 | 204 | 3 | 18393943 | ||
| Pubmed | Structure, alternative splicing, and expression of the human and mouse KCNIP gene family. | 7.92e-07 | 4 | 204 | 3 | 16112838 | |
| Pubmed | GTF3C3 MDN1 PPIL2 FAR1 HSPA2 HSPA5 HSP90AA1 PDCD6IP POLR2B XPOT | 1.55e-06 | 237 | 204 | 10 | 29564676 | |
| Pubmed | FBXO22 promotes leukemogenesis by targeting BACH1 in MLL-rearranged acute myeloid leukemia. | CENPF TOPAZ1 NEB DNAJC7 MAP3K4 MDN1 SCN9A ANK3 POLR2B XIRP2 LMO7 RSBN1L KDM4B XPOT | 1.64e-06 | 497 | 204 | 14 | 36774506 |
| Pubmed | Evidence showing an intermolecular interaction between KChIP proteins and Taiwan cobra cardiotoxins. | 1.97e-06 | 5 | 204 | 3 | 15184042 | |
| Pubmed | Clathrin facilitates the morphogenesis of retrovirus particles. | 1.98e-06 | 16 | 204 | 4 | 21738476 | |
| Pubmed | SART3 TTLL5 TTC1 DNAJC7 DNAJB14 GTF3C3 MDN1 DNAJC1 BAIAP2 FAR1 PIBF1 ADGRL2 HSPA2 HSPA5 CUL2 CASP8AP2 FAM184A NAA15 ANK3 ERO1A POLR2B RALGAPB PPP5C PDCD11 TOP2B | 2.39e-06 | 1487 | 204 | 25 | 33957083 | |
| Pubmed | ZMYND11 MYL6 NET1 HMG20A SQSTM1 MORF4L1 FAR1 ADGRL2 ARAP2 RBL1 POLR2B RNF213 TF ZNF827 SS18L1 PNMA2 SMARCD3 ELF3 RERE ZNF281 RSBN1L | 2.94e-06 | 1116 | 204 | 21 | 31753913 | |
| Pubmed | Gain of Additional BIRC3 Protein Functions through 3'-UTR-Mediated Protein Complex Formation. | SART3 MYL6 CENPF TRPC1 DNAJC7 GTF3C3 MDN1 SQSTM1 TDRD6 FAR1 BSN DNAH5 HSPA5 PDCD6IP NRDC ERO1A POLR2B APOB TMEM43 PPP5C PDCD11 TOP2B LRRFIP2 XPOT | 3.76e-06 | 1425 | 204 | 24 | 30948266 |
| Pubmed | The protein interaction landscape of the human CMGC kinase group. | ASXL1 ZMYND11 PDGFRA NEB YTHDC1 KAT8 BAIAP2 YPEL3 PDCD6IP RBL1 POLR2B PPP5C ARHGAP12 PDCD11 ROCK1 ZNF281 | 3.98e-06 | 695 | 204 | 16 | 23602568 |
| Pubmed | CENPF ASIC1 TRIP11 MDN1 MORF4L1 SYT1 DLG3 BAIAP2 BSN HSP90AA1 CNTN4 PDCD6IP ANK3 NTRK2 HECTD4 NT5C2 ERC2 ROCK1 LRRFIP2 | 4.58e-06 | 963 | 204 | 19 | 28671696 | |
| Pubmed | SART3 YTHDC1 SQSTM1 PDCD6IP POLR2B RNF213 TMEM43 WTAP PDCD11 TOP2B LRRFIP2 | 4.81e-06 | 332 | 204 | 11 | 25693804 | |
| Pubmed | A Human Tyrosine Phosphatase Interactome Mapped by Proteomic Profiling. | SART3 ERLEC1 WWC2 FAR1 ADGRL2 HSPA5 BTRC CUL2 NAA15 PDCD6IP NRDC ERO1A TMEM43 TF ANKRD13A PPP5C PNMA2 FUT8 XPOT | 5.38e-06 | 974 | 204 | 19 | 28675297 |
| Pubmed | MAN2A1 MYL6 PDGFRA DNAJC7 DNAJB14 LCLAT1 PARP4 MDN1 DNAJC1 HSPA2 HSPA5 HSP90AA1 NIBAN1 NAA15 PDCD6IP ERO1A RNF213 ECE1 CTSA MPHOSPH9 FUT8 | 5.92e-06 | 1168 | 204 | 21 | 19946888 | |
| Pubmed | MECP2 directly interacts with RNA polymerase II to modulate transcription in human neurons. | MYL6 YTHDC1 GTF3C3 HMG20A MORF4L1 PPIL2 SRPX HSPA5 HSP90AA1 KRT78 PDCD6IP RBM45 POLR2B HECTD4 TMEM43 WTAP SS18L1 SMARCD3 ZNF281 TOP2B | 6.67e-06 | 1082 | 204 | 20 | 38697112 |
| Pubmed | RUFY1 binds Arl8b and mediates endosome-to-TGN CI-M6PR retrieval for cargo sorting to lysosomes. | MYL6 DNAJC7 TTC4 FAR1 HSPA2 HSPA5 HSP90AA1 PDCD6IP NRDC RNF213 XPOT | 6.72e-06 | 344 | 204 | 11 | 36282215 |
| Pubmed | NEB TTC1 DNAJC7 MAP3K4 VAV3 BAIAP2 PIBF1 HSPA5 HSP90AA1 CASP8AP2 PDCD6IP ANK3 MPHOSPH9 | 6.78e-06 | 486 | 204 | 13 | 20936779 | |
| Pubmed | NET1 RAPGEF5 LCLAT1 WWC2 FMN1 SQSTM1 SYT1 ARMT1 PDCD6IP ANK3 NRDC ERO1A POLR2B ZNF254 APOB WDHD1 ATRNL1 ROCK1 XPOT RAB11FIP3 | 6.85e-06 | 1084 | 204 | 20 | 11544199 | |
| Pubmed | MYOM1 SPTB NEB TRIP11 PARP4 MORF4L1 USP1 HSP90AA1 ARMT1 NRAP ZNF181 PPP5C XIRP2 | 8.61e-06 | 497 | 204 | 13 | 23414517 | |
| Pubmed | MAN2A1 MYL6 DNAJC7 ERLEC1 SQSTM1 MORF4L1 HSPA5 HSP90AA1 CUL2 PDCD6IP NRDC EEF1E1 ERO1A POLR2B APOB TMEM43 ECE1 CTSA PAFAH1B1 NT5C2 PDCD11 XPOT | 8.77e-06 | 1297 | 204 | 22 | 33545068 | |
| Pubmed | 1.06e-05 | 233 | 204 | 9 | 29518331 | ||
| Pubmed | Proteomic analyses of native brain K(V)4.2 channel complexes. | 1.09e-05 | 8 | 204 | 3 | 19713751 | |
| Pubmed | 1.11e-05 | 24 | 204 | 4 | 10617616 | ||
| Pubmed | Genome-wide CRISPR screens identify novel regulators of wild-type and mutant p53 stability. | ZGRF1 BCORL1 DNAJC7 TTC4 TRIP11 SQSTM1 PPIL2 BSN CASP8AP2 RBM20 LMO7 ERC2 ROCK1 LRIF1 | 1.12e-05 | 588 | 204 | 14 | 38580884 |
| Pubmed | 1.32e-05 | 25 | 204 | 4 | 27483141 | ||
| Pubmed | TRPC1 SCN9A UTY BTRC ERO1A NTRK2 LMO7 COX7A2L MAP3K13 CDH5 KDM4B | 1.36e-05 | 371 | 204 | 11 | 15747579 | |
| Pubmed | Calsyntenins function as synaptogenic adhesion molecules in concert with neurexins. | 1.37e-05 | 52 | 204 | 5 | 24613359 | |
| Pubmed | 1.63e-05 | 9 | 204 | 3 | 20877300 | ||
| Pubmed | Targeting USP10 induces degradation of oncogenic ANLN in esophageal squamous cell carcinoma. | SART3 MYL6 CENPF YTHDC1 GTF3C3 SQSTM1 BAIAP2 HSPA5 HSP90AA1 KRT78 NAA15 PDCD6IP DDX60 CAPN1 POLR2B TMEM43 WTAP LMO7 PDCD11 RSBN1L LRRFIP2 | 1.78e-05 | 1257 | 204 | 21 | 36526897 |
| Pubmed | DNAJC7 ERLEC1 PARP4 SQSTM1 BTRC CUL2 EEF1E1 CAPN1 RNF213 TMEM43 ANKRD13A FUT8 | 1.85e-05 | 457 | 204 | 12 | 22190034 | |
| Pubmed | Novel interactors and a role for supervillin in early cytokinesis. | 2.11e-05 | 28 | 204 | 4 | 20309963 | |
| Pubmed | 2.31e-05 | 10 | 204 | 3 | 19584108 | ||
| Pubmed | 2.43e-05 | 29 | 204 | 4 | 21383078 | ||
| Pubmed | DNAJC7 TRIP11 MDN1 STRADA SQSTM1 MORF4L1 HSPA2 CUL2 ANK3 DDX60 CTSA PDCD11 SMARCD3 TOP2B | 2.56e-05 | 634 | 204 | 14 | 34591612 | |
| Pubmed | SART3 DNAJC7 GTF3C3 MDN1 HSPA2 HSPA5 HSP90AA1 NAA15 PDCD6IP POLR2B WDHD1 PDCD11 TOP2B XPOT | 2.74e-05 | 638 | 204 | 14 | 33239621 | |
| Pubmed | ESCPE-1 mediates retrograde endosomal sorting of the SARS-CoV-2 host factor Neuropilin-1. | CLSTN3 MAN2A1 DNAJB14 ERLEC1 GTF3C3 OLFML2A SQSTM1 PPM1L DNAJC1 HSPA2 HSPA5 CA5A ERO1A RNF213 CACHD1 TMEM43 ECE1 CLSTN1 CTSA FUT8 | 2.98e-05 | 1201 | 204 | 20 | 35696571 |
| Pubmed | TTC4 ERLEC1 SQSTM1 PRR14L DNAJC1 BAIAP2 USP1 ERO1A POLR2B AKAP3 RNF213 WDHD1 ROCK1 MPHOSPH9 RSBN1L | 3.16e-05 | 733 | 204 | 15 | 34672954 | |
| Pubmed | ASXL1 CLSTN3 RAPGEF5 RNF157 MAP3K4 DLG3 ADGRL3 ARAP2 RALGAPB ERC2 RERE | 3.18e-05 | 407 | 204 | 11 | 12693553 | |
| Pubmed | 3.42e-05 | 2 | 204 | 2 | 34380759 | ||
| Pubmed | Spitz Tumor With SQSTM1::NTRK2 Fusion: A Clinicopathological Study of 5 Cases. | 3.42e-05 | 2 | 204 | 2 | 36939120 | |
| Pubmed | Interaction of murine BiP/GRP78 with the DnaJ homologue MTJ1. | 3.42e-05 | 2 | 204 | 2 | 10777498 | |
| Pubmed | Upregulation of acid sensing ion channels is associated with esophageal hypersensitivity in GERD. | 3.42e-05 | 2 | 204 | 2 | 34918385 | |
| Pubmed | Extracellular acidosis modulates the endocytosis and maturation of macrophages. | 3.42e-05 | 2 | 204 | 2 | 23435349 | |
| Pubmed | The DREAM protein is associated with thyroid enlargement and nodular development. | 3.42e-05 | 2 | 204 | 2 | 19299442 | |
| Pubmed | 3.42e-05 | 2 | 204 | 2 | 33646123 | ||
| Pubmed | 3.42e-05 | 2 | 204 | 2 | 20015700 | ||
| Pubmed | 3.42e-05 | 2 | 204 | 2 | 28518134 | ||
| Pubmed | ASIC3 Mediates Itch Sensation in Response to Coincident Stimulation by Acid and Nonproton Ligand. | 3.42e-05 | 2 | 204 | 2 | 26440887 | |
| Pubmed | 3.42e-05 | 2 | 204 | 2 | 15618547 | ||
| Pubmed | 3.42e-05 | 2 | 204 | 2 | 21337470 | ||
| Pubmed | 3.42e-05 | 2 | 204 | 2 | 34360710 | ||
| Pubmed | PDGFRalphaalpha signaling is regulated through the primary cilium in fibroblasts. | 3.42e-05 | 2 | 204 | 2 | 16243034 | |
| Pubmed | 3.42e-05 | 2 | 204 | 2 | 18269347 | ||
| Pubmed | 3.42e-05 | 2 | 204 | 2 | 26574545 | ||
| Pubmed | 3.42e-05 | 2 | 204 | 2 | 22933801 | ||
| Pubmed | ASIC1a is required for neuronal activation via low-intensity ultrasound stimulation in mouse brain. | 3.42e-05 | 2 | 204 | 2 | 34569932 | |
| Pubmed | 3.42e-05 | 2 | 204 | 2 | 20693874 | ||
| Pubmed | Insights into degradation mechanism of N-end rule substrates by p62/SQSTM1 autophagy adapter. | 3.42e-05 | 2 | 204 | 2 | 30120248 | |
| Pubmed | 3.42e-05 | 2 | 204 | 2 | 15699139 | ||
| Pubmed | Comparison of TFII-I gene family members deleted in Williams-Beuren syndrome. | 3.42e-05 | 2 | 204 | 2 | 15388857 | |
| Pubmed | 3.42e-05 | 2 | 204 | 2 | 38892470 | ||
| Pubmed | 3.42e-05 | 2 | 204 | 2 | 27139341 | ||
| Pubmed | 3.42e-05 | 2 | 204 | 2 | 31346222 | ||
| Pubmed | 3.42e-05 | 2 | 204 | 2 | 21670278 | ||
| Pubmed | 3.42e-05 | 2 | 204 | 2 | 29634950 | ||
| Pubmed | Elevated CHI3L1 and OPN levels in patients with anti-N-methyl-d-aspartate receptor encephalitis. | 3.42e-05 | 2 | 204 | 2 | 31310926 | |
| Pubmed | Latrophilin GPCRs direct synapse specificity by coincident binding of FLRTs and teneurins. | 3.42e-05 | 2 | 204 | 2 | 30792275 | |
| Pubmed | 3.42e-05 | 2 | 204 | 2 | 18095322 | ||
| Pubmed | 3.42e-05 | 2 | 204 | 2 | 33824228 | ||
| Pubmed | 3.42e-05 | 2 | 204 | 2 | 27385098 | ||
| Pubmed | 3.42e-05 | 2 | 204 | 2 | 10400612 | ||
| Pubmed | 3.42e-05 | 2 | 204 | 2 | 1346273 | ||
| Pubmed | Apoprotein B degradation is promoted by the molecular chaperones hsp90 and hsp70. | 3.42e-05 | 2 | 204 | 2 | 11333259 | |
| Pubmed | 3.42e-05 | 2 | 204 | 2 | 18374609 | ||
| Pubmed | 3.42e-05 | 2 | 204 | 2 | 20110689 | ||
| Pubmed | NET1 DNAJC1 BTRC CUL2 NRAP ANK3 SLC16A9 ASAH2 ATRNL1 ARHGAP12 NT5C2 | 3.80e-05 | 415 | 204 | 11 | 16385451 | |
| Pubmed | CRISPR/Cas9-mediated Genomic Editing of Cluap1/IFT38 Reveals a New Role in Actin Arrangement. | 4.03e-05 | 213 | 204 | 8 | 29615496 | |
| Pubmed | SART3 MYL6 PALMD SQSTM1 SYT1 DLG3 BAIAP2 BSN HSPA2 BTRC ADGRL3 HSP90AA1 NAA15 PDCD6IP ANK3 EEF1E1 NTRK2 TMEM43 PPP5C | 4.63e-05 | 1139 | 204 | 19 | 36417873 | |
| Pubmed | Interaction of U-box-type ubiquitin-protein ligases (E3s) with molecular chaperones. | 5.45e-05 | 13 | 204 | 3 | 15189447 | |
| Pubmed | NET1 DNAJC7 GTF3C3 STRADA SQSTM1 CUL2 NAA15 PDCD6IP XIRP2 SH3PXD2A XPOT | 6.04e-05 | 437 | 204 | 11 | 20562859 | |
| Pubmed | SART3 MYL6 TTC1 DNAJC7 GTF3C3 PARP4 MORF4L1 HSPA5 HSP90AA1 CUL2 POLR2B LARP1B WTAP WDHD1 PDCD11 ERC2 CDH18 | 6.57e-05 | 971 | 204 | 17 | 33306668 | |
| Pubmed | Genome-wide CRISPR screen identifies HNRNPL as a prostate cancer dependency regulating RNA splicing. | SPTB KCNIP3 TTC8 DENND5A BAIAP2 PDCD6IP ANK3 SLC16A9 CAPN1 RALGAPB HECTD4 PSCA RNF213 ZNF827 SH3PXD2A ASMTL NT5C2 DIP2C GREB1 RERE KDM4B DOP1A | 7.00e-05 | 1489 | 204 | 22 | 28611215 |
| Pubmed | 7.44e-05 | 172 | 204 | 7 | 27375898 | ||
| Pubmed | SART3 MAN2A1 NET1 DENND2D YTHDC1 NDUFB3 HMG20A MDN1 SQSTM1 KAT8 MORF4L1 DLG3 DNAJC1 BAIAP2 FAR1 FAM184A POLR2B RALGAPB PDCD11 FUT8 ZNF281 RSBN1L | 7.57e-05 | 1497 | 204 | 22 | 31527615 | |
| Pubmed | 7.79e-05 | 234 | 204 | 8 | 36243803 | ||
| Pubmed | MYC multimers shield stalled replication forks from RNA polymerase. | MYL6 PDGFRA CENPF DNAJC7 YTHDC1 GTF3C3 MDN1 SQSTM1 MORF4L1 PPIL2 HSPA5 HSP90AA1 PDCD6IP CD2 PDCD11 RSBN1L TOP2B | 8.20e-05 | 989 | 204 | 17 | 36424410 |
| Pubmed | 8.44e-05 | 304 | 204 | 9 | 32235678 | ||
| Pubmed | Network organization of the huntingtin proteomic interactome in mammalian brain. | MYL6 SPTB SYT1 DNAJC1 TDRD6 BSN HSPA2 HSPA5 HSP90AA1 CUL2 ERC2 ROCK1 ATP12A | 8.54e-05 | 621 | 204 | 13 | 22794259 |
| Pubmed | Differential impact of tetratricopeptide repeat proteins on the steroid hormone receptors. | 8.59e-05 | 15 | 204 | 3 | 20661446 | |
| GeneFamily | Tetratricopeptide repeat domain containing|Bardet-Biedl syndrome associated|BBSome | 3.65e-06 | 115 | 143 | 8 | 769 | |
| GeneFamily | Potassium voltage-gated channel regulatory subunits|DASH family | 2.06e-04 | 15 | 143 | 3 | 858 | |
| GeneFamily | Cadherin related | 3.04e-04 | 17 | 143 | 3 | 24 | |
| GeneFamily | Adhesion G protein-coupled receptors, subfamily L | 3.69e-04 | 4 | 143 | 2 | 918 | |
| GeneFamily | Acid sensing ion channel subunits | 6.12e-04 | 5 | 143 | 2 | 290 | |
| GeneFamily | Pleckstrin homology domain containing|Rho guanine nucleotide exchange factors|C2 domain containing | 1.27e-03 | 206 | 143 | 7 | 682 | |
| Coexpression | ZHONG_PFC_C3_ASTROCYTE | ASIC1 PALMD MDN1 SCN9A SYT1 BAIAP2 CNTN4 ANK3 LMO7 SH3PXD2A SS18L1 DIP2C RERE KDM4B | 2.18e-06 | 389 | 202 | 14 | M39102 |
| Coexpression | DACOSTA_UV_RESPONSE_VIA_ERCC3_DN | ASXL1 ZMYND11 MAN2A1 CENPF TRPC1 MAP3K4 MDN1 DENND5A PIBF1 BTRC ARAP2 CUL2 POLR2B TDRD7 WDHD1 ARHGAP12 PAFAH1B1 NT5C2 ROCK1 MPHOSPH9 FUT8 | 3.21e-06 | 856 | 202 | 21 | M4500 |
| Coexpression | MANNO_MIDBRAIN_NEUROTYPES_HGABA | RAPGEF5 NEB DNAJB14 RNF157 FSIP2 MDN1 SCN9A SYT1 DLG3 VAV3 BSN ADGRL3 CNTN4 FAM184A ANK3 SLC16A9 MUC19 LARP1B CD2 SH3PXD2A PNMA2 ERC2 KCNIP4 DOP1A | 5.05e-06 | 1106 | 202 | 24 | M39071 |
| Coexpression | LAKE_ADULT_KIDNEY_C6_PROXIMAL_TUBULE_EPITHELIAL_CELLS_FIBRINOGEN_POS_S3 | 1.20e-05 | 181 | 202 | 9 | M39225 | |
| Coexpression | ZAK_PBMC_MRKAD5_HIV_1_GAG_POL_NEF_AGE_20_50YO_1DY_DN | CLSTN3 ZMYND11 NET1 DENND2D LCLAT1 RNF157 ZNF585B MDN1 CASP8AP2 RBL1 TRGC2 POLR2B ZNF254 ATP8B2 ZNF181 CD2 TRBV24-1 ZNF827 ARHGAP12 MPHOSPH9 TOP2B XPOT | 1.25e-05 | 1012 | 202 | 22 | M40864 |
| Coexpression | HAMAI_APOPTOSIS_VIA_TRAIL_UP | SPP1 TTC1 DNAJC7 TRIP11 DNAJB14 DNAJC1 PIBF1 USP1 HSP90AA1 CUL2 ARMT1 CASP8AP2 NAA15 AGGF1 TDRD7 WDHD1 TOP2B | 1.44e-05 | 656 | 202 | 17 | M18979 |
| Coexpression | DESERT_EXTRACELLULAR_MATRIX_HEPATOCELLULAR_CARCINOMA_SUBCLASS_UP | 2.25e-05 | 22 | 202 | 4 | M34033 | |
| Coexpression | GSE22033_WT_VS_PPARG_KO_MEF_DN | 2.55e-05 | 199 | 202 | 9 | M7692 | |
| Coexpression | GSE17301_CTRL_VS_48H_ACD3_ACD28_IFNA5_STIM_CD8_TCELL_DN | MAN2A1 GTF2IRD2 VAV3 DENND5A ARAP2 CNTN4 RBL1 WDHD1 MPHOSPH9 | 2.66e-05 | 200 | 202 | 9 | M8048 |
| Coexpression | SHEN_SMARCA2_TARGETS_UP | ZMYND11 YTHDC1 GTF3C3 HMG20A MORF4L1 PIBF1 USP1 CUL2 ARMT1 RALGAPB AGGF1 PAFAH1B1 ROCK1 | 3.12e-05 | 429 | 202 | 13 | M29 |
| Coexpression | DACOSTA_UV_RESPONSE_VIA_ERCC3_XPCS_DN | 5.13e-05 | 85 | 202 | 6 | M10575 | |
| Coexpression | DE_YY1_TARGETS_DN | 8.49e-05 | 93 | 202 | 6 | M3278 | |
| Coexpression | FLOTHO_PEDIATRIC_ALL_THERAPY_RESPONSE_DN | 9.15e-05 | 31 | 202 | 4 | M4866 | |
| Coexpression | GSE13547_CTRL_VS_ANTI_IGM_STIM_BCELL_2H_UP | 9.16e-05 | 183 | 202 | 8 | M2993 | |
| Coexpression | BLALOCK_ALZHEIMERS_DISEASE_DN | TRPC1 TTC1 KCNIP1 NDUFB3 HMG20A SYT1 BSN ADGRL2 HSPA5 ADGRL3 HSP90AA1 CUL2 CASP8AP2 ANK3 EEF1E1 POLR2B WDHD1 ASMTL PAFAH1B1 PNMA2 COX7A2L NEUROD6 CDH18 | 1.01e-04 | 1248 | 202 | 23 | M17728 |
| Coexpression | IL21_UP.V1_UP | 1.03e-04 | 186 | 202 | 8 | M2827 | |
| Coexpression | GHO_ATF5_TARGETS_UP | 1.22e-04 | 13 | 202 | 3 | M12008 | |
| Coexpression | GSE17301_IFNA2_VS_IFNA5_STIM_ACD3_ACD28_ACT_CD8_TCELL_UP | 1.58e-04 | 198 | 202 | 8 | M8036 | |
| Coexpression | GSE46468_LUNG_INNATE_LYMPHOID_CELL_VS_SPLEEN_CD4_TCELL_DN | 1.63e-04 | 199 | 202 | 8 | M8444 | |
| Coexpression | GSE17721_0.5H_VS_8H_CPG_BMDC_DN | 1.63e-04 | 199 | 202 | 8 | M4127 | |
| Coexpression | GSE17301_CTRL_VS_48H_IFNA2_STIM_CD8_TCELL_UP | 1.69e-04 | 200 | 202 | 8 | M8038 | |
| Coexpression | GSE45881_CXCR6HI_VS_CXCR1LO_COLONIC_LAMINA_PROPRIA_UP | 1.69e-04 | 200 | 202 | 8 | M9889 | |
| Coexpression | GSE3039_ALPHAALPHA_CD8_TCELL_VS_B2_BCELL_UP | 1.69e-04 | 200 | 202 | 8 | M6437 | |
| Coexpression | GSE5142_CTRL_VS_HTERT_TRANSDUCED_CD8_TCELL_EARLY_PASSAGE_CLONE_UP | 1.69e-04 | 200 | 202 | 8 | M6549 | |
| Coexpression | GSE3982_BASOPHIL_VS_TH2_UP | 1.69e-04 | 200 | 202 | 8 | M5566 | |
| Coexpression | GSE39820_CTRL_VS_IL1B_IL6_CD4_TCELL_DN | 1.69e-04 | 200 | 202 | 8 | M5600 | |
| Coexpression | GSE20366_TREG_VS_NAIVE_CD4_TCELL_DEC205_CONVERSION_UP | 1.69e-04 | 200 | 202 | 8 | M4332 | |
| ToppCell | PCW_07-8.5-Epithelial-Epithelial_airway-epi_proximal_progenitor1_(6)|PCW_07-8.5 / Celltypes from embryonic and fetal-stage human lung | RAPGEF5 MYO3B SCN9A ARAP2 NIBAN1 ANK3 GSAP LMO7 ZNF804B ERC2 KCNIP4 ELF3 | 8.21e-11 | 189 | 204 | 12 | 7659c7bbd58ee959a159294fb8d17317bbcc5681 |
| ToppCell | Anterior_Cingulate_gyrus_(CgG)-Neuronal-Glutamatergic_Excit|Anterior_Cingulate_gyrus_(CgG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | RAPGEF5 KCNIP3 PPM1L BAIAP2 ARAP2 LMO7 ERC2 KCNIP4 NEUROD6 CDH18 | 1.57e-08 | 186 | 204 | 10 | 84ba666237c18189d7e7556bd92dd953af733c00 |
| ToppCell | LPS-IL1RA+antiTNF-Endothelial-Endothelial-Activated_Alv_Cap|LPS-IL1RA+antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | RAPGEF5 PPM1L SCN9A ADGRL2 ADGRL3 DDX60 NTRK2 RNF213 TPPP3 CDH5 | 1.66e-08 | 187 | 204 | 10 | f3397dbc23b6c2f24e2c1ba887d8f9aef3ee01a1 |
| ToppCell | PCW_07-8.5-Epithelial-Epithelial_airway|PCW_07-8.5 / Celltypes from embryonic and fetal-stage human lung | 2.35e-08 | 194 | 204 | 10 | f95c8dc242c9aebcadfe61b1ed033349cb7e5a88 | |
| ToppCell | LPS_IL1RA_TNF-Epithelial_alveolar-AT_2-Differentiating_AT2|LPS_IL1RA_TNF / Treatment groups by lineage, cell group, cell type | 3.13e-08 | 200 | 204 | 10 | e8db082aa4d0597500e4f16a5c0ea3e62c6c59ae | |
| ToppCell | Control-Endothelial-Endothelial-Activated_Alv_Cap|Control / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 1.79e-07 | 183 | 204 | 9 | e81c142770f44fd902b0631bc360c5b5339d4c75 | |
| ToppCell | Adult-Epithelial-alveolar_epithelial_cell_type_2/Club-like_(AT2/Club-like)|Adult / Lineage, Cell type, age group and donor | 1.96e-07 | 185 | 204 | 9 | 673f0c688ae6984bc8027df2da335787924f4137 | |
| ToppCell | Children_(3_yrs)-Epithelial-alveolar_epithelial_cell_type_2/Club-like_(AT2/Club-like)|Children_(3_yrs) / Lineage, Cell type, age group and donor | 1.96e-07 | 185 | 204 | 9 | 98b8ee42b89d97e4c9db01740e0c193503c68f2c | |
| ToppCell | Epithelial-alveolar_epithelial_cell_type_2/Club-like_(AT2/Club-like)|World / Lineage, Cell type, age group and donor | 2.15e-07 | 187 | 204 | 9 | 81cc8435b2704a9a8287b3f54acaae0f11dd4ac7 | |
| ToppCell | Mid-temporal_gyrus_(MTG)-Neuronal-Glutamatergic_Excit-Glut_C-D_(RORB)|Mid-temporal_gyrus_(MTG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | RAPGEF5 KCNIP3 PPM1L ADGRL2 ARAP2 ATRNL1 KCNIP4 NEUROD6 CDH18 | 2.24e-07 | 188 | 204 | 9 | 50c1b1d690f0e9443082f2adf4f1b8e9ce4cd337 |
| ToppCell | PCW_07-8.5-Epithelial-Epithelial_airway-epi_proximal_secretory_(0)|PCW_07-8.5 / Celltypes from embryonic and fetal-stage human lung | 2.57e-07 | 191 | 204 | 9 | 60ff989fe99d243a3d52955223680cdd1f1917a4 | |
| ToppCell | IPF-Stromal-SMC|Stromal / Disease state, Lineage and Cell class | 2.68e-07 | 192 | 204 | 9 | 9b06c7336624ef21f8e5393725b56038a8028e57 | |
| ToppCell | LPS-antiTNF-Endothelial-Endothelial-Activated_Alv_Cap|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 2.68e-07 | 192 | 204 | 9 | c618ede75dce3988c87a5b8f98d8e94e1dd66efd | |
| ToppCell | facs-Lung-nan-3m-Endothelial-endothelial_cell_of_lung|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | RAPGEF5 OLFML2A ADGRL2 ADGRL3 ARAP2 FMO1 SLC16A9 CLSTN1 CDH5 | 2.93e-07 | 194 | 204 | 9 | f159ef8541d75a4e98468947f231bb463bec922c |
| ToppCell | RA-03._Atrial_Cardiomyocyte|World / Chamber and Cluster_Paper | 2.93e-07 | 194 | 204 | 9 | 89812fb164065041357bb37a3c2d87028ec3de4e | |
| ToppCell | LPS_anti-TNF-Epithelial_alveolar-AT_2-Differentiating_AT2|LPS_anti-TNF / Treatment groups by lineage, cell group, cell type | 3.33e-07 | 197 | 204 | 9 | 1485933986921ff45669d9b7501c8d17050b3e97 | |
| ToppCell | LPS_only-Epithelial_alveolar-AT_2-Differentiating_AT2|LPS_only / Treatment groups by lineage, cell group, cell type | 3.33e-07 | 197 | 204 | 9 | 1a1bee8da6e04b65935c40373eaee4d6c046d9a1 | |
| ToppCell | LPS_IL1RA-Epithelial_alveolar-AT_2-Differentiating_AT2|LPS_IL1RA / Treatment groups by lineage, cell group, cell type | 3.48e-07 | 198 | 204 | 9 | 285f729140b1df029c24f6ca1d2438470ac51794 | |
| ToppCell | Children_(3_yrs)-Epithelial-alveolar_epithelial_cell_type_1/2_(AT1/AT2-like)-D139|Children_(3_yrs) / Lineage, Cell type, age group and donor | 7.35e-07 | 159 | 204 | 8 | 8680b054622f573a82b1625fb93c2d5db81d1034 | |
| ToppCell | Children_(3_yrs)-Epithelial-alveolar_epithelial_cell_type_2/Club-like_(AT2/Club-like)-D046|Children_(3_yrs) / Lineage, Cell type, age group and donor | 1.02e-06 | 166 | 204 | 8 | c20479fe7a4306320d7f26e78bf956225f00f35a | |
| ToppCell | systemic_lupus_erythematosus-flare-Lymphocytic_T-CD4-positive,_alpha-beta_T_cell-male|systemic_lupus_erythematosus / PBMC cell types (v2) per disease, treatment status, and sex | 1.11e-06 | 168 | 204 | 8 | 5e721268f0baa51d3f640f7f4c41db769ebef210 | |
| ToppCell | 3'-Adult-Distal_Rectal-Epithelial-Tuft-related-BEST4+_epithelial|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 1.27e-06 | 171 | 204 | 8 | 317b70d72a4ca5336cfb6a49dc57f8e2a8a1c736 | |
| ToppCell | 356C-Fibroblasts-Fibroblast-B_(Myofibroblast)-|356C / Donor, Lineage, Cell class and subclass (all cells) | 1.39e-06 | 173 | 204 | 8 | 26e2e674f5d312fa8f61c11b553dc6101f063b16 | |
| ToppCell | 356C-Fibroblasts-Fibroblast-B_(Myofibroblast)|356C / Donor, Lineage, Cell class and subclass (all cells) | 1.39e-06 | 173 | 204 | 8 | 75e26a65071b0d2f30ed0b2aa9859c488f5cf362 | |
| ToppCell | droplet-Heart-nan-3m|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.58e-06 | 176 | 204 | 8 | 749b47eac5436fa34e0d243ffbc6f1897f4e431e | |
| ToppCell | primary_visual_cortex-Neuronal-GABAergic_neuron-Lamp5-Lamp5_Fam19a1_Tmem182|primary_visual_cortex / Per Region, Lineage, Cell class, Cell type, Cell subtype | 1.71e-06 | 124 | 204 | 7 | 690595d710b57b7cff8029a3bb06a8dd7e3c03c1 | |
| ToppCell | droplet-Limb_Muscle-MUSCLE-30m|Limb_Muscle / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.72e-06 | 178 | 204 | 8 | 01dafd19de04eff459253eaa9a35debf8f3deedf | |
| ToppCell | COVID-19-Heart-CM_4|COVID-19 / Disease (COVID-19 only), tissue and cell type | 2.11e-06 | 183 | 204 | 8 | 2902b6e8aa9a6f62bc1a792c971ab7f651a8e676 | |
| ToppCell | LV-15._Ventricular_Cardiomyocyte_III|LV / Chamber and Cluster_Paper | 2.20e-06 | 184 | 204 | 8 | ab7a1620c14a9d9b6be1b47c559931e345e9eef8 | |
| ToppCell | LV-15._Ventricular_Cardiomyocyte_III|World / Chamber and Cluster_Paper | 2.29e-06 | 185 | 204 | 8 | 6baccb26f999145e51b91d94315bf8d4655bef31 | |
| ToppCell | LPS-IL1RA+antiTNF-Stromal_mesenchymal-Lung_smooth_muscle-MatrixFB_->_Myofibroblast|LPS-IL1RA+antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 2.29e-06 | 185 | 204 | 8 | 3b2dfc8f4c87be516265dbecfc251276034d0efd | |
| ToppCell | LPS-IL1RA+antiTNF-Epithelial_alveolar-AT_2-Differentiating_AT2|LPS-IL1RA+antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 2.38e-06 | 186 | 204 | 8 | e83718fabb057100835d3357df407f283d23fe16 | |
| ToppCell | primary_auditory_cortex_(A1C)-Neuronal-Glutamatergic_Excit-Glut_C-D_(RORB)|primary_auditory_cortex_(A1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 2.48e-06 | 187 | 204 | 8 | f18628ffc7ff7c762b8339ba8822cf0c3157f469 | |
| ToppCell | LA-03._Atrial_Cardiomyocyte|World / Chamber and Cluster_Paper | 2.58e-06 | 188 | 204 | 8 | 6d249fe92d51a19da19ec14bb2262d394255d577 | |
| ToppCell | LPS-IL1RA+antiTNF-Endothelial-Endothelial-Alv_Cap|LPS-IL1RA+antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 2.58e-06 | 188 | 204 | 8 | 73f6ec915934154f435a376cb274b058ff7c5f35 | |
| ToppCell | RV-15._Ventricular_Cardiomyocyte_III|World / Chamber and Cluster_Paper | 2.68e-06 | 189 | 204 | 8 | 0a82931b5f6c0a6427ca3edd5e2235ac49099d40 | |
| ToppCell | Somatosensory_Cortex_(S1)-Neuronal-Glutamatergic_Excit-Glut_C-D_(RORB)|Somatosensory_Cortex_(S1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 2.68e-06 | 189 | 204 | 8 | c3df0e3c50af8f1cfb4d790e668bd7f42b276992 | |
| ToppCell | Mid-temporal_gyrus_(MTG)-Neuronal-Glutamatergic_Excit|Mid-temporal_gyrus_(MTG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 2.68e-06 | 189 | 204 | 8 | a75226616340045b581d08429d2e123e041dee55 | |
| ToppCell | Fetal_29-31_weeks-Epithelial-alveolar_epithelial_cell_type_1/2_(AT1/AT2-like)-D150|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | 2.79e-06 | 190 | 204 | 8 | 8aea807a2bcf0b653b4de6202b6ecb0f0683cc2e | |
| ToppCell | LPS_only-Endothelial-Endothelial-Alv_Cap|LPS_only / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 2.79e-06 | 190 | 204 | 8 | 474cbbab8f3b0a6881fa6c92edb78e43999f9ab0 | |
| ToppCell | LPS-IL1RA+antiTNF-Endothelial-Endothelial-Alv_Gen_Intermediate|LPS-IL1RA+antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 2.79e-06 | 190 | 204 | 8 | a3c6eec6df052105ab78b7e3c78f94218d5912eb | |
| ToppCell | primary_auditory_cortex_(A1C)-Neuronal-Glutamatergic_Excit|primary_auditory_cortex_(A1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 2.79e-06 | 190 | 204 | 8 | 49e09cdb843b3d889a06a811aa5affae68b25a75 | |
| ToppCell | COVID-19-Heart-CM_4|Heart / Disease (COVID-19 only), tissue and cell type | 2.79e-06 | 190 | 204 | 8 | 3729648a17093b438398b82e32bbccc3af7b8c5d | |
| ToppCell | Children_(3_yrs)-Epithelial|Children_(3_yrs) / Lineage, Cell type, age group and donor | 2.90e-06 | 191 | 204 | 8 | e432c6e1ae82dddf84314ce73d2b7a991630d905 | |
| ToppCell | LA-03._Atrial_Cardiomyocyte|LA / Chamber and Cluster_Paper | 2.90e-06 | 191 | 204 | 8 | 5d1b674eb7703830b7ce8bbeac3363cabd0e6ae9 | |
| ToppCell | Fetal_29-31_weeks-Epithelial-alveolar_epithelial_cell_type_1/2_(AT1/AT2-like)|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | 2.90e-06 | 191 | 204 | 8 | ca5669bd6f4a17471acae3eb229f845cc2e08efa | |
| ToppCell | Epithelial-alveolar_epithelial_cell_type_1/2_(AT1/AT2-like)|World / Lineage, Cell type, age group and donor | 2.90e-06 | 191 | 204 | 8 | d3733c8c4bda70c4390e5601fdda6188a64be944 | |
| ToppCell | Epithelial|World / Lineage, Cell type, age group and donor | 3.02e-06 | 192 | 204 | 8 | 499e8893afea5e6d3371e0bd018f7e86a524d669 | |
| ToppCell | Children_(3_yrs)-Epithelial-alveolar_epithelial_cell_type_2-D139|Children_(3_yrs) / Lineage, Cell type, age group and donor | 3.02e-06 | 192 | 204 | 8 | cc9911e182a289779a2612bc213daae5607689e7 | |
| ToppCell | LV-04._Ventricular_Cardiomyocyte_I|LV / Chamber and Cluster_Paper | 3.02e-06 | 192 | 204 | 8 | ad19e2c1d36a0566c9b12ced10db78f4781c8ea6 | |
| ToppCell | Fetal_29-31_weeks-Mesenchymal-myofibroblast_cell-D150|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | 3.02e-06 | 192 | 204 | 8 | 72881b280a415e65f87a80ca1369cbb0b722a0c4 | |
| ToppCell | Adult-Epithelial|Adult / Lineage, Cell type, age group and donor | 3.02e-06 | 192 | 204 | 8 | efb962a5fd3b9bdfd8cf8d13c435e29c8271713e | |
| ToppCell | LPS-IL1RA-Endothelial-Endothelial-Activated_Alv_Cap|LPS-IL1RA / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 3.13e-06 | 193 | 204 | 8 | a3636c35ed25aabe2f1aba016c9fe125327bbfaf | |
| ToppCell | PCW_13-14-Epithelial-Epithelial_airway-epi_proximal_secretory_(0)|PCW_13-14 / Celltypes from embryonic and fetal-stage human lung | 3.13e-06 | 193 | 204 | 8 | b38aaffbea36ef6c08ebe82675438f873c89b242 | |
| ToppCell | PND10-Endothelial-Endothelial_blood-vessel-Microvascular_EC|PND10 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 3.13e-06 | 193 | 204 | 8 | 097a244cf37ce6c1ace9bae56beb7de59442cd6b | |
| ToppCell | LPS-IL1RA-Endothelial|LPS-IL1RA / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 3.26e-06 | 194 | 204 | 8 | 43f92b0533e26633dc94cce554045d641ef8fd76 | |
| ToppCell | LPS-IL1RA-Endothelial-Endothelial|LPS-IL1RA / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 3.26e-06 | 194 | 204 | 8 | 1d39d968730a7e85b6161c1c8a6bd38afe9bcad7 | |
| ToppCell | PND03-Endothelial-Endothelial_blood-vessel-Microvascular_EC|PND03 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 3.38e-06 | 195 | 204 | 8 | d700e959e060932e3854a9cf294799465efbe18b | |
| ToppCell | ASK440-Endothelial-Endothelium|ASK440 / Donor, Lineage and Cell class of Lung cells from Dropseq | 3.38e-06 | 195 | 204 | 8 | 304f0dc91bb57e98b0ca31d6bfb3ff9364e4da56 | |
| ToppCell | Neuron-Postmitotic-Excitatory_Neuron_-Layer_VI_Pan-area|World / Primary Cells by Cluster | 3.65e-06 | 197 | 204 | 8 | 79b9e7f2e8e33b3c547f716be5667156c48b0dfc | |
| ToppCell | Control_saline-Epithelial_alveolar-AT_2-Differentiating_AT2|Control_saline / Treatment groups by lineage, cell group, cell type | 3.65e-06 | 197 | 204 | 8 | 44a59dfb889577b3160a5b13ada1276771a00241 | |
| ToppCell | Bronchial_Biopsy-Mesenchymal-Smooth_muscle|Mesenchymal / Tissue, Lineage and Cell class of Lung Cells from 10X | 3.65e-06 | 197 | 204 | 8 | 98f0184a09563a544f0c2d4df22c9db2fbc95019 | |
| ToppCell | Neuron-Postmitotic-Excitatory_Neuron_-Layer_VI_Pan-area-33|World / Primary Cells by Cluster | 3.65e-06 | 197 | 204 | 8 | d20f29088e9afd8a960d6f680075c380e550f8a7 | |
| ToppCell | tumor_Lung-Fibroblasts-Smooth_muscle_cells|Fibroblasts / Location, Cell class and cell subclass | 3.79e-06 | 198 | 204 | 8 | f540f464118edc0fb809ebcb813d0302e6952253 | |
| ToppCell | LPS_IL1RA_TNF-Epithelial_alveolar-AT_2|LPS_IL1RA_TNF / Treatment groups by lineage, cell group, cell type | 3.79e-06 | 198 | 204 | 8 | aa80315395cb5dffc25927c8a77cd2037aea8772 | |
| ToppCell | Bronchial-NucSeq-Epithelial|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 3.93e-06 | 199 | 204 | 8 | 5f7da3eab58ace6cddb3179a415cd839d5767958 | |
| ToppCell | Parenchymal-NucSeq-Epithelial|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 3.93e-06 | 199 | 204 | 8 | 5cea0d9e261903e0eaad60c28a07dff72ce65027 | |
| ToppCell | LPS_only-Mesenchymal_fibroblastic-Fibroblasts-Activated_MatrixFB|LPS_only / Treatment groups by lineage, cell group, cell type | 3.93e-06 | 199 | 204 | 8 | fde2b65afde69f402f1b7b056eaa266e9fd5b227 | |
| ToppCell | Tracheal-10x3prime_v2-Endothelial-Endothelia_vascular-VE_systemic_arterial|10x3prime_v2 / Cell types per location group and 10X technology with lineage, and cell group designations | 3.93e-06 | 199 | 204 | 8 | bd43a84e84d8acb8e1008b98a235cc5bd5f43586 | |
| ToppCell | Smart-start-Cell-Wel_seq-Non-neoplastic-Glial-Neuronal-OPC-OPC-G|Smart-start-Cell-Wel_seq / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 3.93e-06 | 199 | 204 | 8 | 19a97e27a4758e794ce7246d295e112b47931a48 | |
| ToppCell | LPS_IL1RA_TNF-Epithelial_alveolar-AT_1-Differentiating_AT2|LPS_IL1RA_TNF / Treatment groups by lineage, cell group, cell type | 3.93e-06 | 199 | 204 | 8 | 121de4e02585de3a3010398387c523bacf8ce546 | |
| ToppCell | LPS_IL1RA-Mesenchymal_fibroblastic-Fibroblasts-Diff_MatrixFB|LPS_IL1RA / Treatment groups by lineage, cell group, cell type | 3.93e-06 | 199 | 204 | 8 | 38ed3bc7daa993d9edcf3e7834597ebb06dd24f8 | |
| ToppCell | 10x3'2.3-week_17-19-Mesenchymal_fibro-stroma|week_17-19 / cell types per 3 fetal stages;per 3',per 5' | 4.08e-06 | 200 | 204 | 8 | 747c61d4e0b746278ae1f45ca4cd556c6961c76a | |
| ToppCell | Parenchymal-10x3prime_v2-Endothelial-Endothelia_vascular-VE_systemic_arterial|10x3prime_v2 / Cell types per location group and 10X technology with lineage, and cell group designations | 4.08e-06 | 200 | 204 | 8 | a8b59e6fe04271fef61db911a286b5c48438bb84 | |
| ToppCell | LPS_IL1RA_TNF-Endothelial|LPS_IL1RA_TNF / Treatment groups by lineage, cell group, cell type | 4.08e-06 | 200 | 204 | 8 | d01cec331be3b03cef80e9536fc531285bcf00f6 | |
| ToppCell | Neuronal-Excitatory|Neuronal / cells hierarchy compared to all cells using T-Statistic | 4.08e-06 | 200 | 204 | 8 | 4409065bc7aa995354c71e0f9d6f3726cf393d6b | |
| ToppCell | 10x3'2.3-week_17-19-Mesenchymal_fibro|week_17-19 / cell types per 3 fetal stages;per 3',per 5' | 4.08e-06 | 200 | 204 | 8 | de1d193f773f4e2927baa6fc38d29754b015c6e6 | |
| ToppCell | LPS_IL1RA_TNF-Endothelial-Endothelial|LPS_IL1RA_TNF / Treatment groups by lineage, cell group, cell type | 4.08e-06 | 200 | 204 | 8 | a1fa6bae5a688faf488d6925cd3fad725dfa916b | |
| ToppCell | Frontal_cortex-Neuronal-Excitatory-eN2(Slc17a7_Slc17a6)-Syt6|Frontal_cortex / BrainAtlas - Mouse McCarroll V32 | 6.04e-06 | 150 | 204 | 7 | 9d5bbdca19da60e1a2121ef64ec8e1375a5dbf6d | |
| ToppCell | normal-na-Lymphocytic_T-CD8-positive,_alpha-beta_T_cell-male|normal / PBMC cell types (v2) per disease, treatment status, and sex | 7.50e-06 | 155 | 204 | 7 | 08295584395e8d9cfc1b1648f98754b3ac53e587 | |
| ToppCell | PND01-03-samps-Endothelial-Postnatal_endothelial-endothelial_cells_C|PND01-03-samps / Age Group, Lineage, Cell class and subclass | 7.82e-06 | 156 | 204 | 7 | 6c8f442ed94ae31e6832b68137e98ae78091ac6c | |
| ToppCell | 3'-Airway_Nasal-Epithelial-Epithelial_transtional-secretory-nasal_mucosa_goblet_cell-Goblet_(nasal)-Goblet_(nasal)_L.0.2.2.0|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 8.15e-06 | 157 | 204 | 7 | c43f2e1ea53b375a7432f17f87cfef3b2261003d | |
| ToppCell | PND01-03-samps|World / Age Group, Lineage, Cell class and subclass | 9.61e-06 | 161 | 204 | 7 | 1973b112d8d67aacc02751797d0148e7b53bfa66 | |
| ToppCell | Adult-Epithelial-alveolar_epithelial_cell_type_1/2_(AT1/AT2-like)|Adult / Lineage, Cell type, age group and donor | 1.04e-05 | 163 | 204 | 7 | e819a1d6d28290854aa0672b3a18fa9e293d8f23 | |
| ToppCell | Hippocampus-Neuronal-Inhibitory-iN2(Gad1Gad2)-Tox|Hippocampus / BrainAtlas - Mouse McCarroll V32 | 1.12e-05 | 64 | 204 | 5 | bf923a66b17e717b8d3817b9d0e201b82a7e4a88 | |
| ToppCell | Hippocampus-Neuronal-Inhibitory-iN2(Gad1Gad2)-Tox-Inhibitory_Gad1Gad2_Cplx3.Tox_(Interneuron,_lacunosum_oriens1?)|Hippocampus / BrainAtlas - Mouse McCarroll V32 | 1.12e-05 | 64 | 204 | 5 | a3e852600c53b11175eb579e92962fa711f5678b | |
| ToppCell | Hippocampus-Neuronal-Inhibitory-iN2(Gad1Gad2)-Tox-Inhibitory_Gad1Gad2_Cplx3.Tox_(Interneuron,_lacunosum_oriens1?)-|Hippocampus / BrainAtlas - Mouse McCarroll V32 | 1.12e-05 | 64 | 204 | 5 | f8f43ad9354c786b418bac54614f96f50e8bea68 | |
| ToppCell | Substantia_nigra-Neuronal-Inhibitory-iN1(Gad1Gad2_Th)-Th|Substantia_nigra / BrainAtlas - Mouse McCarroll V32 | 1.17e-05 | 166 | 204 | 7 | 6a6ed5c7a43fee9a8a9be42dfa99303815b8e8ef | |
| ToppCell | 3'_v3-lymph-node_spleen-Lymphocytic_T_CD8-Trm_gut_CD8|lymph-node_spleen / Manually curated celltypes from each tissue | 1.22e-05 | 167 | 204 | 7 | 69de7d7fc69d699eab03dfea84fdb54263aa5a47 | |
| ToppCell | P28-Epithelial-epithelial_progenitor_cell|P28 / developmental_time, Lineage, Cell group, Cell type, Cell type_cellcyc-phase | 1.27e-05 | 168 | 204 | 7 | 03c95ad3684caec7a6d581006b237cc5fa230685 | |
| ToppCell | Control|World / group, cell type (main and fine annotations) | 1.27e-05 | 168 | 204 | 7 | a3511faf2cd2c2b9c8363c8b99da3f3609c43ed6 | |
| ToppCell | LV-16._Neuronal|LV / Chamber and Cluster_Paper | 1.32e-05 | 169 | 204 | 7 | a8fc8ab0f0757e939e213efb61c03cfe390bf7d2 | |
| ToppCell | Children_(3_yrs)-Epithelial-alveolar_epithelial_cell_type_1/2_(AT1/AT2-like)-D032|Children_(3_yrs) / Lineage, Cell type, age group and donor | 1.37e-05 | 170 | 204 | 7 | a2c738e441ced90eeeb1fcc6ca3269b918aaa298 | |
| ToppCell | COVID-19-Heart-CM_+_Macrophage|Heart / Disease (COVID-19 only), tissue and cell type | 1.37e-05 | 170 | 204 | 7 | 4232fe937909f93d3736988c707b8f95ce993398 | |
| ToppCell | 3'-Child04-06-SmallIntestine-Mesenchymal-Pericytes-Contractile_pericyte_(PLN+)|Child04-06 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 1.71e-05 | 176 | 204 | 7 | 90f36f10c6ed440a0ca549f23219398853f1fbc3 | |
| ToppCell | Adult-Epithelial-alveolar_epithelial_cell_type_2/Club-like_(AT2/Club-like)-D122|Adult / Lineage, Cell type, age group and donor | 1.71e-05 | 176 | 204 | 7 | 3fee8a367bb9755aca1b7fcc968b08e51b6e9436 | |
| ToppCell | CV-Severe-7|CV / Virus stimulation, Condition and Cluster | 1.71e-05 | 176 | 204 | 7 | 3de0c7d77210049e5616db21eed1490a17a5ec2d | |
| ToppCell | TCGA-Brain-Primary_Tumor-Low_Grade_Glioma|TCGA-Brain / Sample_Type by Project: Shred V9 | 1.78e-05 | 177 | 204 | 7 | e8ab340b20cd41554c3841fe980e078e878af35f | |
| ToppCell | (06)_Krt4/13+|World / shred by cell type and Timepoint | 1.84e-05 | 178 | 204 | 7 | 46efdf03aa1317bc600138e871509b995e773cce | |
| ToppCell | Children_(3_yrs)-Epithelial-alveolar_epithelial_cell_type_2/Club-like_(AT2/Club-like)-D032|Children_(3_yrs) / Lineage, Cell type, age group and donor | 1.84e-05 | 178 | 204 | 7 | f5ed4a6e3eb8056b1be1fb311021710c95bdf888 | |
| Disease | X-13548 measurement | 4.53e-05 | 2 | 199 | 2 | EFO_0021353 | |
| Disease | Childhood Medulloblastoma | 2.02e-04 | 43 | 199 | 4 | C0278510 | |
| Disease | Melanotic medulloblastoma | 2.02e-04 | 43 | 199 | 4 | C1275668 | |
| Disease | Medullomyoblastoma | 2.02e-04 | 43 | 199 | 4 | C0205833 | |
| Disease | Desmoplastic Medulloblastoma | 2.02e-04 | 43 | 199 | 4 | C0751291 | |
| Disease | Adult Medulloblastoma | 2.02e-04 | 43 | 199 | 4 | C0278876 | |
| Disease | short-term memory | 2.51e-04 | 83 | 199 | 5 | EFO_0004335 | |
| Disease | Medulloblastoma | 3.63e-04 | 50 | 199 | 4 | C0025149 | |
| Disease | systemising measurement | 3.67e-04 | 21 | 199 | 3 | EFO_0010221 | |
| Disease | medulloblastoma (is_marker_for) | 4.47e-04 | 5 | 199 | 2 | DOID:0050902 (is_marker_for) | |
| Disease | Alcohol Related Birth Defect | 6.67e-04 | 6 | 199 | 2 | C3146244 | |
| Disease | age at menarche | NDST4 HMG20A BSN ADGRL2 ARMT1 ATRNL1 LRRC53 ERC2 GREB1 RERE FUT8 KDM4B | 7.56e-04 | 594 | 199 | 12 | EFO_0004703 |
| Disease | uric acid measurement | TSHR HMGCS2 FMN1 SYT1 ADGRL2 CNTN4 SLC16A9 HECTD4 ZNF827 DIP2C NEUROD6 KDM4B | 9.51e-04 | 610 | 199 | 12 | EFO_0004761 |
| Disease | Bilateral Wilms Tumor | 9.70e-04 | 29 | 199 | 3 | C2930471 | |
| Disease | coronary artery disease (is_marker_for) | 1.10e-03 | 67 | 199 | 4 | DOID:3393 (is_marker_for) | |
| Disease | post-traumatic stress disorder (biomarker_via_orthology) | 1.58e-03 | 9 | 199 | 2 | DOID:2055 (biomarker_via_orthology) | |
| Disease | Nephroblastoma | 1.83e-03 | 36 | 199 | 3 | C0027708 | |
| Disease | Primary ciliary dyskinesia | 1.83e-03 | 36 | 199 | 3 | cv:C0008780 | |
| Disease | postburn hypertrophic scarring severity measurement | 1.97e-03 | 10 | 199 | 2 | EFO_0007747 | |
| Disease | head circumference | 1.97e-03 | 10 | 199 | 2 | EFO_0005114 | |
| Disease | alcohol drinking | 2.23e-03 | 81 | 199 | 4 | EFO_0004329 | |
| Disease | Alcoholic Intoxication, Chronic | 2.37e-03 | 268 | 199 | 7 | C0001973 | |
| Disease | retinal vasculature measurement | TTLL5 HMG20A MYO3B DNAJC1 DNAH5 PIWIL2 XIRP2 SH3PXD2A ZNF804B ERC2 | 2.82e-03 | 517 | 199 | 10 | EFO_0010554 |
| Disease | disks large homolog 3 measurement | 2.86e-03 | 12 | 199 | 2 | EFO_0802472 | |
| Disease | schizophrenia (is_marker_for) | 3.27e-03 | 44 | 199 | 3 | DOID:5419 (is_marker_for) | |
| Disease | Fetal Alcohol Spectrum Disorders | 3.36e-03 | 13 | 199 | 2 | C2985290 | |
| Disease | Kartagener syndrome (implicated_via_orthology) | 3.90e-03 | 14 | 199 | 2 | DOID:0050144 (implicated_via_orthology) | |
| Disease | Asbestosis | 3.90e-03 | 14 | 199 | 2 | C0003949 | |
| Disease | Pulmonary Fibrosis - from Asbestos Exposure | 3.90e-03 | 14 | 199 | 2 | C2930617 | |
| Disease | Celiac Disease | 3.94e-03 | 47 | 199 | 3 | C0007570 | |
| Disease | FEV/FEC ratio | ASXL1 DENND2D NEB TTC1 KCNIP1 WWC2 CTAGE1 DENND5A DNAH5 ARAP2 FAM184A NAA15 EEF1E1 SH3PXD2A ARHGAP12 ERC2 TOP2B | 4.14e-03 | 1228 | 199 | 17 | EFO_0004713 |
| Disease | schizophrenia, anorexia nervosa | 4.18e-03 | 48 | 199 | 3 | MONDO_0005090, MONDO_0005351 | |
| Disease | cholesteryl ester 20:3 measurement | 4.43e-03 | 49 | 199 | 3 | EFO_0010347 | |
| Disease | susceptibility to measles measurement | 4.43e-03 | 49 | 199 | 3 | EFO_0008414 | |
| Disease | triacylglycerol 46:0 measurement | 4.49e-03 | 15 | 199 | 2 | EFO_0010400 | |
| Disease | neurotic disorder | 4.93e-03 | 101 | 199 | 4 | EFO_0004257 | |
| Disease | unipolar depression, sex interaction measurement | 4.96e-03 | 51 | 199 | 3 | EFO_0003761, EFO_0008343 | |
| Disease | fourth ventricle volume measurement | 5.10e-03 | 16 | 199 | 2 | EFO_0010303 | |
| Disease | thyroid volume | 5.10e-03 | 16 | 199 | 2 | EFO_0004865 | |
| Disease | Drug-induced agranulocytosis | 5.10e-03 | 16 | 199 | 2 | HP_0012235 | |
| Disease | ceramide measurement | 5.36e-03 | 235 | 199 | 6 | EFO_0010222 | |
| Disease | Fetal Alcohol Syndrome | 5.76e-03 | 17 | 199 | 2 | C0015923 | |
| Disease | Febrile seizure (within the age range of 3 months to 6 years) | 6.45e-03 | 18 | 199 | 2 | HP_0002373 | |
| Disease | age-related hearing impairment | 6.64e-03 | 324 | 199 | 7 | EFO_0005782 |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| YLEYQQSLLNESDGK | 91 | Q9H993 | |
| EEKETGQKINIHEYY | 136 | Q96DZ1 | |
| YEQKLNEYVAKGLTD | 106 | P19397 | |
| ENTEKLQYSGERLYK | 201 | Q9BQT9 | |
| KEYEGYEVESSLKNA | 71 | Q96RT6 | |
| EVGKVFLATNSDYKY | 241 | P49902 | |
| LAQYDNESKKNYGSQ | 191 | P51813 | |
| DQDIYKVSIYDTKGK | 101 | P06729 | |
| ETSKGVYCLQYDDQK | 301 | Q9Y297 | |
| KSRKYQTGEYLTEQE | 1336 | Q5H9F3 | |
| DNEATGNKIDYIYNT | 331 | Q9HAR2 | |
| GNKIDYIYNTDQSKD | 336 | Q9HAR2 | |
| NKLRETGKEAYNVSY | 576 | Q5VU97 | |
| ALDNESEVKGYKVLY | 926 | Q8IWV2 | |
| NESETGKNSIDYIYN | 331 | O95490 | |
| RVKYGLQNTEYEDEK | 566 | Q8N302 | |
| DNLIQQYKYETGLSD | 1691 | Q5JWR5 | |
| ISYQVEKNKYDASAI | 76 | P78545 | |
| KFDGLSISYYNNEKE | 506 | Q8WZ64 | |
| EKSYKATVIEGKQYD | 166 | O94985 | |
| LEKAYAKVNGSYEAL | 191 | P07384 | |
| GTAKEATYNDLQVEY | 66 | Q9UKL3 | |
| YQILKGKEYFAIDNS | 191 | P33151 | |
| LIQDAGQFYAKYKET | 241 | Q96KC8 | |
| EDYEGKLNKAQSFYE | 246 | Q8NB25 | |
| EDYYGQKLGLTKEES | 356 | Q8IXJ9 | |
| KDEYEKFSGAYVNNR | 61 | Q9P241 | |
| IKYEYTIQKDGLDND | 806 | P58397 | |
| QKLDTYQEYKEAASS | 461 | Q9BUB4 | |
| KNEGELYYKAQSPDE | 501 | P98198 | |
| EEKTQAYYVIKAAQE | 656 | Q9UFE4 | |
| AVGAEYYLESLNKDK | 81 | O43676 | |
| VQYYQEKSAVINGEK | 571 | Q5T481 | |
| EPKNKASESSEQDYY | 191 | Q8IUH3 | |
| EEKAKQDPSYYLKNT | 186 | Q13356 | |
| SSEEKQLYNKYPDAV | 26 | P10451 | |
| ATVYGAEQVKDLTKY | 231 | O75154 | |
| EKVGLKYTEAEYQAA | 711 | Q68DA7 | |
| SNGYEEAYSVFKKEA | 21 | P43034 | |
| SILEDYANYKKSRGN | 231 | Q9UBU8 | |
| SDINLKKGESECQYY | 351 | Q7Z628 | |
| QGDTQSELLDYKNYE | 66 | Q96LL4 | |
| DKAEVVNGYEAKVYT | 256 | Q8IZ07 | |
| NAYIGVTYKNEEDKL | 986 | P16234 | |
| YSIYNEKGKNLEENI | 211 | Q7RTY1 | |
| QKYNADYELSAKQGA | 76 | Q5HYI7 | |
| GIKVYDDGQKSVYAV | 206 | Q9NP74 | |
| IKQGSDAYDAQTYDV | 5151 | Q9NU22 | |
| YTKALAEYVVQQEGA | 206 | Q8WVX9 | |
| EYYTHEKQEKGTLNS | 696 | Q5T3J3 | |
| ADYVLYKNKVEDSGI | 731 | Q16706 | |
| AEYQKEVNYELVTGK | 581 | Q4ZG55 | |
| QAAKASGEIISDYKY | 1051 | Q86VF7 | |
| ELEQYQKTEAYKVFS | 166 | Q9NP66 | |
| YRKSNISVYEVDGKD | 241 | Q9H7Z6 | |
| KTDSYNKEYTLDQNE | 936 | A6NM62 | |
| SDNVGYASYLLEQEK | 316 | Q9NR71 | |
| LGKKAEDLFQDAYYQ | 406 | O95671 | |
| EKDYVNDLKDSYGQE | 906 | P54707 | |
| EKTEKNGEYSINYEG | 91 | Q8WX39 | |
| NAFAEKNGLQKYEYV | 216 | Q6UWP7 | |
| DEITYGLKKNVYEQQ | 3406 | Q9UPA5 | |
| LKNIAFYYENENVKG | 381 | Q8IY21 | |
| QQSGTNKEFYYDIKD | 6431 | Q5CZC0 | |
| VGYDDQESVKSKVQY | 326 | P36222 | |
| TDLEKYNNVEAGKYT | 71 | P54868 | |
| ESYTYNIKQTVEDEK | 546 | P54652 | |
| IYYITGETKDQVANS | 176 | Q58FG0 | |
| TVAKNKDQGTYEDYV | 76 | P60660 | |
| YDEYVNVKDFSDKIN | 291 | Q8WUM4 | |
| TGECEKTAKYNYDIL | 8316 | Q7Z5P9 | |
| NLYDINKDGYITKEE | 166 | Q6PIL6 | |
| YYESEINSLKQKLEA | 461 | Q99550 | |
| KDFNKYVAYIESQGA | 26 | O94953 | |
| SKAEAEALYQTKYQE | 296 | Q8N1N4 | |
| ELDDYSTNKNGNNKY | 1426 | Q8WWI1 | |
| EALNYETVEQKKAYE | 416 | Q9UHC3 | |
| FADQIKQLDKEASYY | 701 | O15083 | |
| KTYQEEGEKVSAYVL | 256 | Q9UL42 | |
| TDNGKGKYTLVIYEN | 121 | Q9H3R1 | |
| ASEYFENYIEELKKQ | 211 | Q9UKK3 | |
| LTYNYVKKFESINDE | 3746 | Q9Y4D8 | |
| KTQQTSPDKVDYEYS | 176 | Q9BXJ9 | |
| TFNLYDINKDGYINK | 141 | Q9NZI2 | |
| SLDEKSDKQYAENYT | 291 | Q9Y608 | |
| DENSKAFYVPAQYVK | 56 | Q8IWW6 | |
| GKAYSTDYKLQQQDT | 146 | O43283 | |
| SSQKYQILLYNGDVD | 386 | P10619 | |
| SVKYQNYKEAVVGEN | 161 | P35218 | |
| VERNGNIIYTYKDDK | 51 | A4D1B5 | |
| NIIYTYKDDKGNVVF | 56 | A4D1B5 | |
| EYSQDLDAYNTKDKI | 1991 | P04114 | |
| NGSVYINQSKAIDYE | 871 | Q9BYE9 | |
| RSGNYQKALDTYKDT | 666 | Q13099 | |
| ETGNAYEDLSQKYKA | 1031 | P49454 | |
| TENLGVVYYVNKDFK | 291 | Q8TBM8 | |
| SVVKVEDGQASLYKY | 341 | Q01740 | |
| YAGKEYIIQVAAKDN | 271 | P26992 | |
| GEYYKQEASNLLQES | 216 | Q13617 | |
| NNDTAYIEYKTCKDG | 491 | Q9Y2E4 | |
| EGNEIKYYKNNTDDG | 356 | Q5U5Z8 | |
| EYEADLEAKNKDGYT | 146 | Q92527 | |
| KDYNLTKVIDYLTND | 2026 | Q12955 | |
| GLVDDLYKYEVNTKT | 496 | Q5VV63 | |
| LSDDYYGAKNLKGQE | 596 | Q92796 | |
| EKAQTYYETLEKNEV | 1171 | Q6IQ26 | |
| TSDSTVYDYAGKNKV | 46 | O14548 | |
| DGIKSASYKYSEEAN | 111 | Q96HE7 | |
| NYEKKKSYTLNIEGA | 336 | Q13634 | |
| DYYKILGVDKNASED | 381 | Q99615 | |
| KLKERIEENGYNTYA | 151 | O15520 | |
| DYYLNKTENEKVLTG | 266 | P42892 | |
| QQDKFYDVSYDTGDK | 366 | Q6ZQY3 | |
| IYYITGETKDQVANS | 491 | P07900 | |
| YVQALEGKYTDLNSN | 36 | Q15007 | |
| EKGTIYDYEAIALNK | 36 | O75715 | |
| AVSVKKESEDPNYYQ | 231 | Q86UP8 | |
| AVSVKKESEDPNYYQ | 231 | Q6EKJ0 | |
| ESYAYSLKNQIGDKE | 566 | P11021 | |
| FNLYDINKDGYITKE | 171 | Q9Y2W7 | |
| CVDDSQDYYVGKKNI | 61 | O43653 | |
| KGLAYVEYENESQAS | 841 | Q15020 | |
| YYVQAVNDKNGDNKT | 181 | Q58EX2 | |
| AGYFQQKILEYEEQK | 446 | Q9H6A0 | |
| DATNEAKDNVKYLYT | 336 | Q8TE73 | |
| FQEETKKDYESGQLY | 796 | Q659C4 | |
| EFSLEEIYTNKNYKS | 2041 | Q5THK1 | |
| FTYYKAGKQEVTEAV | 291 | Q68BL7 | |
| KDLNSYLEDKVYLTG | 96 | O43324 | |
| ALKDVSYKIYDDENQ | 176 | Q9GZY0 | |
| KDTGKTVENVEEYSY | 126 | Q9Y6R4 | |
| EAKTKYPNYEFISDN | 416 | Q9BYC5 | |
| KDYVGKNLDTKNYDS | 301 | Q6PCB5 | |
| EKLGKLQYSLDYDFQ | 141 | P21579 | |
| VGDKATKESYAIQYL | 256 | O14607 | |
| QNLQGYDAKSDIYSV | 251 | Q7RTN6 | |
| DGQVKKETRYSYNTE | 136 | Q9BTV4 | |
| YREEGNKKFQEKDYT | 71 | Q8IYR2 | |
| IYGIENKYNTQDSKV | 251 | Q96PX1 | |
| AQAGYAKYQEFETKE | 661 | O60522 | |
| GLQYKKSYDDAESLK | 536 | Q02880 | |
| DPKYNYSKDANDVIT | 116 | P03986 | |
| TDNSKAVNKEYEEYV | 296 | P28749 | |
| YSKNYGITVKEEDQP | 456 | Q8TC59 | |
| AKDYENAIKFYSQAI | 41 | P53041 | |
| YEGTLGKYNVNEDAK | 46 | P0DMR2 | |
| LQDYEKDKENSVLSY | 151 | Q5SGD2 | |
| VDSVNVDKQPKYEYS | 1416 | Q15858 | |
| LQDSHDKEYINGDKY | 296 | Q6STE5 | |
| YSAKKYQGKEENSDV | 126 | Q92565 | |
| YRSYKEQESKKGFDQ | 811 | P30876 | |
| QEDYYSRLKKEGDKQ | 1551 | Q9P2R6 | |
| YVDYGFSENVEKSKA | 546 | Q8NHU6 | |
| KIQYTVYDRAENKGT | 236 | P78539 | |
| YYDTNTGKEGKLDIV | 456 | Q6UX06 | |
| NYDIGAALDTIQYSK | 421 | Q13501 | |
| IAAELYISNKQYDKA | 331 | Q9Y5Q9 | |
| KYSDKELQYIDAISN | 156 | Q9UQB8 | |
| KQGELENYVSDGYKT | 171 | Q9UQB8 | |
| KIDGSENKCVYQSLY | 146 | O75969 | |
| NYETIEQKKAYEIAG | 416 | P78348 | |
| LEYQSKGKTAECTQY | 36 | O75177 | |
| NGDYTLIAKNEYGKD | 356 | Q16620 | |
| TQLYDKGYTSKEQKD | 556 | P48995 | |
| EEIEKQKQESSYYNI | 2381 | A4UGR9 | |
| YAVEKLSKENNSYSV | 4896 | Q63HN8 | |
| YAKSEKFQEAGELYN | 1701 | Q14690 | |
| VDEYKVHKEGYNELN | 151 | Q8TF32 | |
| VQKEGYNELKEYLTT | 156 | Q8NE65 | |
| SAAEYYKEVLKQDNT | 336 | Q8TAM2 | |
| KYNLDYSDSEPNKSE | 551 | A4D1E1 | |
| DYQYKLDFLLQEKSG | 481 | Q6AWC2 | |
| QTFYYAVAVVKKDSG | 111 | P02787 | |
| VVVKNDYAVESYENK | 91 | Q9BZQ8 | |
| NNLKDVYVSIADYEG | 1071 | Q5TCZ1 | |
| GYEYEESTKNQATKE | 746 | O75717 | |
| QGDYRQENYDKVKSE | 256 | Q8WXW3 | |
| ASSQDQKIYSGEKSY | 116 | Q52M93 | |
| QEYSKYLQQAFEKST | 666 | Q9Y2X9 | |
| LNKGDANSEVTVYYQ | 911 | O43847 | |
| YNFGVETQKNNKYEE | 226 | Q8IYF3 | |
| YYSFDVKDINKGEIS | 66 | A0A075B6N3 | |
| YEGTLGKYNVNEDAK | 46 | Q8TD33 | |
| KEQIYSSLDYGKDLT | 656 | P11277 | |
| NGQKKVLYYADALTE | 1246 | Q86X10 | |
| STKGKSATEYKNEEY | 86 | Q96MU7 | |
| ILENSKSQTDKDYYQ | 591 | Q13464 | |
| VSAYKNAGTYDAKVK | 161 | Q9BW30 | |
| SEASYGEVQENYKLS | 41 | Q17R98 | |
| VEFQDELYKNTPKYS | 196 | Q8N9V7 | |
| IQEKVNEGKYRSYEE | 201 | Q15326 | |
| DYTGLIQSYEQNETK | 1266 | Q15643 | |
| KKLTYDEEYNFENEG | 381 | O43592 | |
| YNYSVKDLQEISGSE | 1251 | Q86YA3 | |
| QFKKGDYIEAESSYS | 126 | Q99614 | |
| EEQAKTYKDEGNDYF | 76 | O95801 | |
| CKSVDEYKVNKEGYN | 126 | O75437 | |
| GQKSKADYELYNKAS | 671 | O94782 | |
| ADYELYNKASNPDKV | 676 | O94782 | |
| QKEGEDASLYSKRYN | 1011 | Q6EMB2 | |
| SYEFSNSKKNLEYIE | 111 | Q2M3W8 | |
| YEENLGDSIVGYKEK | 326 | P16473 | |
| EQAFESSQKYKEGKY | 91 | P61236 | |
| KESGEYAISIKYNNE | 701 | Q9UKW4 | |
| GQIKVLDGEDEYYKS | 1296 | Q8WXR4 | |
| QKTVDLSGQAYDEAY | 1541 | P52179 | |
| VAAQNSDKSYKAEYE | 696 | P20929 | |
| QAASDVQYKKDYEKA | 1081 | P20929 | |
| YDLQSQLQYTAAGKE | 4626 | P20929 | |
| FSLKQEETLDYGKNY | 271 | Q96NK8 |